Table 4.
Covariate | Coefficient (mean) | Coefficient (95 CI) | P-value |
---|---|---|---|
(Intercept) | −7.26 | (− 7.31, −7.21) | < 0.001a |
Age | 0.047 | (0.046, 0.048) | < 0.001a |
Ferritin | 4.93E−05 | (4.39e−05, 5.47e−05) | < 0.001a |
BUN | 0.018 | (0.017, 0.018) | < 0.001a |
Mechanical_Ventilation | 2.83 | (2.81, 2.85) | < 0.001a |
Ondansetron | −0.63 | (− 0.64, −0.62) | 0.001a |
Ddimer | 0.043 | (0.036, 0.051) | 0.001a |
Heart_Failure | 0.47 | (0.46, 0.49) | 0.01a |
Remdesivir | 0.4 | (0.38, 0.42) | 0.03a |
Neoplastic_Disease | −0.76 | (− 0.78, − 0.73) | 0.03a |
COPD | 0.33 | (0.32, 0.34) | 0.13 |
Gender_male | 0.24 | (0.24, 0.25) | 0.14 |
CRP | 0.001 | (0.001, 0.001) | 0.15 |
Lymphocytes | −0.16 | (− 0.16, − 0.15) | 0.17 |
CAD | 0.26 | (0.25, 0.26) | 0.18 |
Dexamethasone | −0.26 | (− 0.27, − 0.25) | 0.2 |
AST | 0.002 | (0.001, 0.002) | 0.22 |
ALT | −0.002 | (− 0.002, −0.002) | 0.24 |
Race_white | −0.17 | (−0.19, − 0.15) | 0.26 |
Convalescent_plasma | 0.2 | (0 .19, 0.21) | 0.34 |
Azithromycin | −0.16 | (− 0.17, − 0.15) | 0.36 |
Ethnicity_Hispanic | 0.068 | (0.010, 0.126) | 0.42 |
Diabetes | −0.059 | (− 0.068, − 0.051) | 0.71 |
Tocilizumab | −0.037 | (− 0.052, − 0.022) | 0.82 |
Asthma | −0.05 | (− 0.064, − 0.036) | 0.82 |
Kidney_disease | −0.02 | (− 0.033, − 0.006) | 0.87 |
ALT alanine aminotransferase, AST aspartate transaminase, BUN blood urea nitrogen, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, CRP C-reactive protein
aDenotes significance; negative sign means a significant association with decreased mortality